June 2016 - Restech

Home
Our solutions
- First
- Resmon Pro
- Resolve
Company
About Oscillometry
Contacts

RESMON PRO FULL received 510(K) clearance from U.S. FDA

RESMON PFO FULL device has been approved by the U.S. Food and Drug Administration and it is now available in the U.S. through our distributor...

Jun 24, 2016

Company

via Melchiorre Gioia, 63/61
20124 Milan Italy
T: (+39) 02.36.59.36.90
F: (+39) 02.36.59.36.92

REA: MI-1936811| RESTECH P.IVA/CF: 07116980967
privacy policy

The first mini-oscillometer, a revolution in pulmonary diagnostics.

First is a novel, revolutionary unique medical device for easy, fast, reliable measurements of respiratory function at normal tidal breathing, all in a compact stand-alone handheld device. First utilizes the proven and validated method of OSCILLOMETRY or FOT (forced oscillatory technique) to detect and localize peripheral and central obstructions, as well as tidal Expiratory Flow Limitation (EFLt).

Discover more

SCIENTIFIC PAPERS

1. Walker PP, Pompilio PP, Zanaboni P, et al. Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial. Am J Respir Crit Care Med. 2018;198(5):620-628. doi:10.1164/rccm.201712-2404OC

2. Gobbi A, Milesi I, Govoni L, Pedotti A, Dellacà RL. A New Telemedicine System for the Home Monitoring of Lung Function in Patients with Obstructive Respiratory Diseases. 2009 Int Conf eHealth, Telemedicine, Soc Med. February 2009:117-122. doi:10.1109/eTELEMED.2009.18

3. Zimmermann SC, Huvanandana J, Nguyen CD, et al. Day-to-day variability of forced oscillatory mechanics for early detection of acute exacerbations in COPD. Eur Respir J. 2020;56(3). doi:10.1183/13993003.01739-2019

4. Gobbi A, Gulotta C, Suki B, et al. Monitoring of respiratory resistance in the diagnosis of mild-intermittent asthma. Clin Exp Allergy. 2019:0-1. doi:10.1111/cea.13376

5. Gobbi A, Dellacá RL, King G, Thamrin C. Toward Predicting Individual Risk in Asthma Using Daily Home Monitoring of Resistance. Am J Respir Crit Care Med. 2017;195(2):265-267. doi:10.1164/rccm.201603-0537LE